Folgen
Gregor Berger
Gregor Berger
Privatdozent der Universität Zürich
Bestätigte E-Mail-Adresse bei kjpd.uzh.ch - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Long-chain ω-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial
GP Amminger, MR Schäfer, K Papageorgiou, CM Klier, SM Cotton, ...
Archives of general psychiatry 67 (2), 146-154, 2010
12962010
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia
C Pantelis, M Yücel, SJ Wood, D Velakoulis, D Sun, G Berger, GW Stuart, ...
Schizophrenia bulletin 31 (3), 672-696, 2005
7042005
Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?
AR Yung, HP Yuen, G Berger, S Francey, TC Hung, B Nelson, L Phillips, ...
Schizophrenia bulletin 33 (3), 673-681, 2007
5482007
Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study
GP Amminger, GE Berger, MR Schäfer, C Klier, MH Friedrich, M Feucht
Biological psychiatry 61 (4), 551-553, 2007
5092007
Intervention in individuals at ultra high risk for psychosis: a review and future directions
PD McGorry, B Nelson, GP Amminger, A Bechdolf, SM Francey, G Berger, ...
The Journal of clinical psychiatry 70 (9), 9320, 2009
4302009
ADHD: Current concepts and treatments in children and adolescents
R Drechsler, S Brem, D Brandeis, E Grünblatt, G Berger, S Walitza
Neuropediatrics 51 (05), 315-335, 2020
4072020
Effect of ω-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial
PD McGorry, B Nelson, C Markulev, HP Yuen, MR Schäfer, N Mossaheb, ...
JAMA psychiatry 74 (1), 19-27, 2017
3012017
Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders
LJ Phillips, PD McGorry, B Garner, KN Thompson, C Pantelis, SJ Wood, ...
Australian & New Zealand Journal of Psychiatry 40 (9), 725-741, 2006
2872006
Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis
B Garner, CM Pariante, SJ Wood, D Velakoulis, L Phillips, B Soulsby, ...
Biological psychiatry 58 (5), 417-423, 2005
2612005
Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.
GE Berger, TM Proffitt, M McConchie, HP Yuen, SJ Wood, GP Amminger, ...
Journal of Clinical Psychiatry 68 (12), 1867-1875, 2007
2142007
Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome
PD McGorry, B Nelson, LJ Phillips, HP Yuen, SM Francey, A Thampi, ...
The Journal of clinical psychiatry 74 (4), 10030, 2013
2052013
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ...
The Lancet Psychiatry 5 (10), 797-807, 2018
2002018
Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis
AR Yung, LJ Phillips, B Nelson, SM Francey, H PanYuen, MB Simmons, ...
The Journal of clinical psychiatry 71 (4), 16654, 2010
1962010
Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis
SJ Borgwardt, PK McGuire, J Aston, G Berger, P Dazzan, ...
The British Journal of Psychiatry 191 (S51), s69-s75, 2007
1902007
Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies
P Fusar-Poli, G Berger
Journal of clinical psychopharmacology 32 (2), 179-185, 2012
1562012
Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals
SJ Wood, G Berger, D Velakoulis, LJ Phillips, PD McGorry, AR Yung, ...
Schizophrenia Bulletin 29 (4), 831-843, 2003
1562003
Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study
GE Berger, SJ Wood, RM Wellard, TM Proffitt, M McConchie, ...
Neuropsychopharmacology 33 (10), 2467-2473, 2008
1512008
PACE: a specialised service for young people at risk of psychotic disorders.
AR Yung, PD McGorry, SM Francey, B Nelson, K Baker, LJ Phillips, ...
Medical Journal of Australia 187, 2007
1432007
Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation
SJ Wood, GE Berger, RM Wellard, TM Proffitt, M McConchie, M Berk, ...
Neurobiology of disease 33 (3), 354-357, 2009
1282009
Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals
GP Amminger, S Leicester, AR Yung, LJ Phillips, GE Berger, SM Francey, ...
Schizophrenia research 84 (1), 67-76, 2006
1242006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20